Evidence map›Paper›PMID 32258910›Full record

ArticleACS omega2020

Simple Peptide Quantification Approach for MS-Based Proteomics Quality Control.

Teresa Mendes Maia, An Staes, Kim Plasman, Jarne Pauwels, Katie Boucher, Andrea Argentini, Lennart Martens, Tony Montoye, Kris Gevaert, Francis Impens

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A framework for quality control in quantitative proteomics.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Proteomics: A Tool to Study Platelet Function.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Teresa Mendes MaiaVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
An StaesVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Kim PlasmanAlzheimer Research Foundation, Kalkhoevestraat 1, Waregem 8790, Belgium.
Jarne PauwelsVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Katie BoucherVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Andrea ArgentiniVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Lennart MartensVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Tony MontoyeBusiness Development Management, VIB, Ghent 9000, Belgium.
Kris GevaertVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Francis ImpensVIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Ghent University · BEResearch Foundation - Flanders · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite its growing popularity and use, bottom-up proteomics remains a complex analytical methodology. Its general workflow consists of three main steps: sample preparation, liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), and computational data analysis. Quality assessment of the different steps and components of this workflow is instrumental to identify technical flaws and avoid loss of precious measurement time and sample material. However, assessment of the extent of sample losses along with the sample preparation protocol, in particular, after proteolytic digestion, is not yet routinely implemented because of the lack of an accurate and straightforward method to quantify peptides. Here, we report on the use of a microfluidic UV/visible spectrophotometer to quantify MS-ready peptides directly in the MS-loading solvent, consuming only 2 μL of sample. We compared the performance of the microfluidic spectrophotometer with a standard device and determined the optimal sample amount for LC-MS/MS analysis on a Q Exactive HF mass spectrometer using a dilution series of a commercial K562 cell digest. A careful evaluation of selected LC and MS parameters allowed us to define 3 μg as an optimal peptide amount to be injected into this particular LC-MS/MS system. Finally, using tryptic digests from human HEK293T cells and showing that injecting equal peptide amounts, rather than approximate ones, result in less variable LC-MS/MS and protein quantification data. The obtained quality improvement together with easy implementation of the approach makes it possible to routinely quantify MS-ready peptides as a next step in daily proteomics quality control.

Identifiers

PMID32258910
PMCPMC7114614
OpenAlexW3011812214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.